The use of tricyclic antidepressants in the treatment of temporomandibular joint disorders: Systematic review of the literature of the last 20 years

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 14, Issue 1, 2009, Pages

  Cascos Romero, Jordi ^a   Vázquez Delgado, Eduardo ^a,b   Vázquez Rodríguez, Eduardo ^a,b   Gay Escoda, Cosme ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO MÉDICO TEKNON   (Spain)

Author keywords

Amitriptyline; Orofacial pain; Temporomandibular disorders; Tricyclic antidepressants

Indexed keywords

TRICYCLIC ANTIDEPRESSANT AGENT;

COCHRANE LIBRARY; DENTISTRY; DRUG USE; HUMAN; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; PUBLICATION; REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; TEMPOROMANDIBULAR JOINT DISORDER;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; TEMPOROMANDIBULAR JOINT DISORDERS; TIME FACTORS;

EID: 59949085662     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. De Bont LG, Dijkgraaf LC, Stegenga B. Epidemiology and natural progression of articular temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jan;83(1):72-6.
2. Macfarlane TV, Gray RJM, Kincey J, Worthington HV. Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case-control study. Oral Dis. 2001 Nov;7(6):321-30.
3. Martorell-Calatayud L, García-Mira B, Peñarrocha-Diago M. Orofacial pain management: an update. Med Oral. 2004 Aug-Oct;9(4):293-9.
4. Bermejo-Fenoll A, Sáez-Yuguero R. Differential diagnosis of temporomandibular joint disorders (TMD). Med Oral Patol Oral Cir Bucal. 2005 Nov-Dec;10(5):468-9.
5. Emshoff R, Bösch R, Pümpel E, Schöning H, Strobl H. Low-level laser therapy for treatment of temporomandibular joint pain: a double-blind and placebo-controlled trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Apr;105(4):452-6.
6. Carlson CR. Psychological considerations for chronic orofacial pain. Oral Maxillofac Surg Clin North Am. 2008 May;20(2):185-95.
7. Buschmann K. Psychological treatment of chronic headache and facial pain. Schmerz. 2007 Apr;21(2):167-77.
8. Haas DA. Pharmacologic considerations in the management of temporo-mandibular disorders. J Can Dent Assoc. 1995 Feb;61(2):105-9, 112-4.
9. Rizzatti-Barbosa CM, Nogueira MT, De Andrade ED, Ambrosano GM, De Barbosa JR. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio. 2003 Jul;21(3):221-5.
10. Pettengill CA, Reisner-Keller L. The use of tricyclic antidepressants for the control of chronic orofacial pain. Cranio. 1997 Jan;15(1):53-6.
11. Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004 Feb 1;69(3):548-56.
12. Reisner-Keller LA. Pharmacotherapeutics in the management of orofacial pain. Dent Clin North Am. 1997 Apr;41(2):259-78.
13. Dionne RA. Pharmacologic treatments for temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jan;83(1):134-42.
14. Tversky J, Reade PC, Gerschman JA, Holwill BJ, Wright J. Role of depressive illness in the outcome of treatment of temporomandibular joint pain-dysfunction syndrome. Oral Surg Oral Med Oral Pathol. 1991 Jun;71(6):696-9.
15. Harris M, Feinmann C, Wise M, Treasure F. Temporomandibular joint and orofacial pain: clinical and medicolegal management problems. Br Dent J. 1993 Feb 20;174(4):129-36.
16. Denucci DJ, Dionne RA, Dubner R. Identifying a neurobiologic basis for drug therapy in TMDs. J Am Dent Assoc. 1996 May;127(5):581-93.
17. Barker EL, Blakely RD. Identification of a single amino acid, phen-ylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol Pharmacol. 1996 Oct;50(4):957-65.
18. Plesh O, Curtis D, Levine J, McCall WD Jr. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil. 2000 Oct;27(10):834-41.
19. List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac Pain. 2003 Fall;17(4):301-10.
20. Poveda Roda R, Bagan JV, Díaz Fernández JM, Hernández Bazán S, Jimenéz Soriano Y. Review of temporomandibular joint pathology. Part I: classification, epidemiology and risk factors. Med Oral Patol Oral Cir Bucal. 2007 Aug 1;12(4):E292-8.
21. Tollison CD, Kriegel ML. Selected tricyclic antidepressants in the management of chronic benign pain. South Med J. 1988 May;81(5):562-4.
22. Satterthwaite JR, Tollison CD, Kriegel ML. The use of tricyclic antidepressants for the treatment of intractable pain. Compr Ther. 1990 Apr;16(4):10-5.
23. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 1992 May;49(2):205-19.
24. Kreisberg MK. Tricyclic antidepressants: analgesic effect and indications in orofacial pain. J Craniomandib Disord. 1988 Fall;2(4):171-7.
25. Ardid D, Guilbaud G. Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain. 1992 May;49(2):279-87.
26. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain. 1987 Nov;31(2):199-209.
27. McQuay HJ, Carroll D, Glynn CJ. Low dose amitriptyline in the treatment of chronic pain. Anaesthesia. 1992 Aug;47(8):646-52.
28. McQuay HJ, Carroll D, Glynn CJ. Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia. 1993 Apr;48(4):281-5.
29. Zitman FG, Linssen AC, Edelbroek PM, Stijnen T. Low dose amitriptyline in chronic pain: the gain is modest. Pain. 1990 Jul;42(1):35-42.